Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts
- PMID: 6263305
- PMCID: PMC2010633
- DOI: 10.1038/bjc.1981.67
Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts
Abstract
The effect of melphalan on the growth of 4 different lines of human lung-tumour xenografts has been established. The oat-cell carcinoma was the most sensitive, whereas the adenocarcinoma was the most resistant. Two lines of large-cell anaplastic carcinomas were intermediate in sensitivity. The differences in sensitivity were not reflected in the gross uptake of drug into the tumours. There was, with the exception of the adenocarcinoma line, a marked decrease in uptake per g tumour with increasing tumour size. This was partly caused by a decrease in the vascular supply in the same tumours with increasing tumour size. Extravasation of plasma proteins increased with increasing tumour size in all tumours, but was much less pronounced in the adenocarcinoma than in the other tumour lines. The extracellular volume of the various tumour lines did not vary with tumour size.
Similar articles
-
A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft.Eur J Cancer (1965). 1979 Dec;15(12):1425-9. doi: 10.1016/0014-2964(79)90020-3. Eur J Cancer (1965). 1979. PMID: 535604 No abstract available.
-
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.Br J Cancer. 1994 Nov;70(5):886-92. doi: 10.1038/bjc.1994.415. Br J Cancer. 1994. PMID: 7947094 Free PMC article.
-
Lung tumour cell lines synthesizing peptide hormones established from tumours of four histological types: characterization of the cell lines and analysis of their peptide hormone production.Br J Cancer. 1985 Jun;51(6):865-75. doi: 10.1038/bjc.1985.132. Br J Cancer. 1985. PMID: 2988594 Free PMC article.
-
The response to chemotherapy of a variety of human tumour xenografts.Br J Cancer. 1983 Jan;47(1):1-13. doi: 10.1038/bjc.1983.1. Br J Cancer. 1983. PMID: 6336942 Free PMC article. Review.
-
Intratumour factors influencing the access of antibody to tumour cells.Cancer Immunol Immunother. 1989;28(4):235-40. doi: 10.1007/BF00205231. Cancer Immunol Immunother. 1989. PMID: 2649244 Free PMC article. Review.
Cited by
-
High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.Br J Cancer. 1983 Feb;47(2):215-9. doi: 10.1038/bjc.1983.29. Br J Cancer. 1983. PMID: 6297529 Free PMC article.
-
Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.Br J Cancer. 1984 Apr;49(4):431-6. doi: 10.1038/bjc.1984.69. Br J Cancer. 1984. PMID: 6324838 Free PMC article.
-
Predictive tests in cancer chemotherapy. A reappraisal.Klin Wochenschr. 1984 Mar 1;62(5):203-12. doi: 10.1007/BF01721045. Klin Wochenschr. 1984. PMID: 6371370 Review.
-
Human tumor xenografts as model for drug testing.Cancer Metastasis Rev. 1988 Nov;7(3):263-84. doi: 10.1007/BF00047755. Cancer Metastasis Rev. 1988. PMID: 3067903 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical